Effects of a Sodium-Glucose Cotransporter 2 Inhibitor Dapagliflozin on Pancreas in Obese Diabetic Mice
In Vivo · 2026
DOI: 10.21873/invivo.14227 ↗Kurz gefasst
Fachartikel in der Zeitschrift In Vivo, 2026. Verfasst von Ryoko Sekikawa und 8 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Animal Physiology and Functional Anatomy, Graduate School of Agriculture, Kyoto University, Kyoto, Japan. Hauptthemen laut MEDLINE: Benzhydryl Compounds, Glucosides, Sodium-Glucose Transporter 2 Inhibitors, Diabetes Mellitus, Type 2. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Animal Physiology and Functional Anatomy, Graduate School of Agriculture, Kyoto University, Kyoto, Japan.
- Laboratory of Animal Physiology and Functional Anatomy, Graduate School of Agriculture, Kyoto University, Kyoto, Japan; uno.kinuko.8s@kyoto-u.ac.jp.
- Tokyo Animal & Diet Dept, CLEA Japan Inc., Tokyo, Japan.
Zitieren
APA
Sekikawa, R., Uehara, H., Uno, K., Sasase, T., Nakata, Y., Mori, Y., Shinohara, M., Sugimoto, M., & Ohta, T. (2026). Effects of a Sodium-Glucose Cotransporter 2 Inhibitor Dapagliflozin on Pancreas in Obese Diabetic Mice. In Vivo. https://doi.org/10.21873/invivo.14227
Vancouver
Sekikawa R, Uehara H, Uno K, Sasase T, Nakata Y, Mori Y, et al. Effects of a Sodium-Glucose Cotransporter 2 Inhibitor Dapagliflozin on Pancreas in Obese Diabetic Mice. In Vivo. 2026. doi:10.21873/invivo.14227
BibTeX
@article{Sekikawa2026,
author = {Sekikawa, Ryoko and Uehara, Hikari and Uno, Kinuko and Sasase, Tomohiko and Nakata, Yusuke and Mori, Yukina and Shinohara, Masami and Sugimoto, Miki and Ohta, Takeshi},
title = {Effects of a Sodium-Glucose Cotransporter 2 Inhibitor Dapagliflozin on Pancreas in Obese Diabetic Mice},
journal = {In Vivo},
year = {2026},
doi = {10.21873/invivo.14227}
}
EUVIMED